Document:

Cost Plus, Inc.'s 1996 Director Option Plan, as amended  and restated

 Exhibit 4.2 
 COST PLUS, INC. 
 1996 DIRECTOR OPTION PLAN 
 (Amended June 19, 1997) 
 (Amended June 15, 1999) 
 (Amended June 22, 2000) 
 (Amended June 27, 2002) 
 (Amended July 1, 2004) 
 (Amended June 29, 2005) 
 (Amended June 22, 2006) 
 (Amended June 18, 2009) 
 1. Purposes of the Plan. The purposes of this 1996 Director Option Plan are to attract and retain the best available personnel for
service as Outside Directors (as defined herein) of the Company, to provide additional incentive to the Outside Directors of the Company to serve as Directors, and to encourage their continued service on the Board. 
 All options granted hereunder shall be nonstatutory stock options. 
 2. Definitions. As used herein, the following definitions shall apply: 
 (a) “Board”
means the Board of Directors of the Company. 
 (b) “Code” means the Internal Revenue Code of 1986, as amended. 

(c) “Common Stock” means the Common Stock of the Company. 
 (d) “Committee” means a committee appointed by the Board to administer the Plan and to perform the functions set forth herein, or, if no
such committee is appointed, the Board. 
 (e) “Company” means Cost Plus, Inc., a California corporation. 
 (f) “Director” means a member of the Board. 

 (g) “Employee” means any person, including officers and Directors, employed by the
Company or any Parent or Subsidiary of the Company. The payment of a Director’s fee by the Company shall not be sufficient in and of itself to constitute “employment” by the Company. 
 (h) “Exchange Act” means the Securities Exchange Act of 1934, as amended. 
 (i) “Fair Market Value” means, as of any date, the value of Common Stock determined as follows: 
 (i) If the Common Stock is listed on any established stock exchange or a national market system, including without limitation the Nasdaq National Market
or The Nasdaq SmallCap Market of The Nasdaq Stock Market, its Fair Market Value shall be the closing sales price for such stock (or the closing bid, if no sales were reported) as quoted on such exchange or system for the day of determination, as
reported in The Wall Street Journal or such other source as the Administrator deems reliable; 
 (ii) If the Common Stock is
regularly quoted by a recognized securities dealer but selling prices are not reported, the Fair Market Value of a Share of Common Stock shall be the mean between the high bid and low asked prices for the Common Stock on the date of determination,
as reported in The Wall Street Journal or such other source as the Board deems reliable, or; 
 (iii) In the absence of an
established market for the Common Stock, the Fair Market Value thereof shall be determined in good faith by the Board. 
 (j) “Inside
Director” means a Director who is an Employee. 
 (k) “Option” means a stock option granted pursuant to the Plan.

 (l) “Optioned Stock” means the Common Stock subject to an Option. 
 (m) “Optionee” means a Director or an entity that holds an Option. 
 (n) “Outside Director” means a Director who is not an Employee. 
 (o) “Parent” means a “parent corporation,” whether now or hereafter existing, as defined in Section 424(e) of the Code.

 (p) “Plan” means this 1996 Director Option Plan. 
 (q) “Representative Director” means a Director who is a member of the Board as the representative for an entity that employs such
Director. The determination of whether an Outside Director is a Representative Director shall be determined by the representations of such Director and such determination may be changed at any time by such Director. 
 (r) “Share” means a share of the Common Stock, as adjusted in accordance with Section 10 of the Plan. 
 (s) “Subsidiary” means a “subsidiary corporation,” whether now or hereafter existing, as defined in Section 424(f) of the
Internal Revenue Code of 1986. 
  

 -2- 

 3. Stock Subject to the Plan. Subject to the provisions of Section 10 of
the Plan, the maximum aggregate number of Shares which may be optioned and sold under the Plan is 1,003,675 Shares of Common Stock. The Shares may be authorized, but unissued, or reacquired Common Stock. 
 If an Option expires or becomes unexercisable without having been exercised in full, the unpurchased Shares which were subject thereto shall become
available for future grant or sale under the Plan (unless the Plan has terminated). Shares that have actually been issued under the Plan shall not be returned to the Plan and shall not become available for future distribution under the Plan.

 4. Administration and Grants of Options under the Plan. 
 (a) The Plan shall be administered by the Committee which shall hold meetings at such times as may be necessary for the proper administration of the Plan.
The Committee shall keep minutes of its meetings. Except as otherwise provided in the Company’s Articles of Incorporation or By-Laws, a quorum shall consist of a majority of the members of the Committee and a majority of a quorum may authorize
any action. Except as otherwise provided in the Company’s Articles of Incorporation or Bylaws, any decision or determination reduced to writing and signed by the requisite number of the members of the Committee shall be as fully effective as if
made by the vote of the requisite number of members at a meeting duly called and held. 
 (b) The Committee shall be composed of the Board of
Directors or a committee appointed by the Board. 
 (c) Subject to the express terms and conditions set forth herein, the Committee shall
have the power from time to time: 
 (i) to determine those individuals to whom Options shall be granted under the Plan and the number of
Shares subject to each Option to be granted, to prescribe the terms and conditions (which need not be identical) of each such Option, including the Fair Market Value on any date, and to make any amendment or modification to any option agreement,
including the acceleration of vesting, consistent with the terms of the Plan; 
 (ii) to construe and interpret the Plan and the Options
granted hereunder and to establish, amend and revoke rules and regulations for the administration of the Plan, including, but not limited to, correcting any defect or supplying any omission, or reconciling any inconsistency in the Plan or in any
Agreement, in the manner and to the extent it shall deem necessary or advisable so that the Plan complies with applicable law, and otherwise to make the Plan fully effective. All decisions and determinations by the Committee in the exercise of this
power shall be final, binding and conclusive upon the Company, its Subsidiaries, the Optionees, and all other persons having any interest therein; 
 (iii) to exercise its discretion with respect to the powers and rights granted to it as set forth in the Plan; and 
 (iv)
generally, to exercise such powers and to perform such acts as are deemed necessary or advisable to promote the best interests of the Company with respect to the Plan. 
 (d) Procedure for Grants. The terms of an Option granted hereunder shall be as follows: 
 (i) the
term of the Option shall be up to ten (10) years. 
  

 -3- 

 (ii) subject to Sections 8 and 10 hereof, the Option shall be exercisable: 
 (A) in the event of an Option held directly by an Outside Director, only while the Outside Director remains a Director of the Company. 
 (B) in the event of an Option held by an entity pursuant to Section 5(b) hereof, only while the Representative Director remains a Director of the
Company. 
 (iii) the exercise price per Share shall be 100% of the Fair Market Value per Share on the date of grant of the Option. In the
event that the date of grant of the Option is not a trading day, the exercise price per Share shall be the Fair Market Value on the next trading day immediately following the date of grant of the Option. 
 (iv) subject to Section 10 hereof, the Option shall become exercisable as determined by the Committee at the time of grant of the Option.

 5. Eligibility. 
 (a)
Except as provided in Section 5(b) hereof, Options may be granted only to Outside Directors. 
 (b) In the event an Outside Director is
a Representative Director, Options shall be granted in the name of the entity employing such Representative Director and such Representative Director shall not personally receive any option grants in the Representative Director’s own name.

 (c) The Plan shall not confer upon any Outside Director any right with respect to continuation of service as a Director or nomination to
serve as a Director, nor shall it interfere in any way with any rights which the Director or the Company may have to terminate the Director’s relationship with the Company at any time. 
 6. Term of Plan. The Plan shall become effective upon the earlier to occur of its adoption by the Board or its approval by the
shareholders of the Company as described in Section 16 of the Plan. It shall continue in effect until March 31, 2016 unless sooner terminated under Section 11 of the Plan. 
 7. Form of Consideration. The consideration to be paid for the Shares to be issued upon exercise of an Option, including the method of payment,
shall consist of (i) cash, (ii) check, (iii) other shares which (x) in the case of Shares acquired upon exercise of an Option, have been owned by the Optionee for more than six (6) months on the date of surrender, and
(y) have a Fair Market Value on the date of surrender equal to the aggregate exercise price of the Shares as to which said Option shall be exercised, (iv) delivery of a properly executed exercise notice together with such other
documentation as the Company and the broker, if applicable, shall require to effect an exercise of the Option and delivery to the Company of the sale or loan proceeds required to pay the exercise price, or (v) any combination of the foregoing
methods of payment. 
 8. Exercise of Option. 
 (a) Procedure for Exercise; Rights as a Shareholder. Any Option granted hereunder shall be exercisable at such times as are set forth in Section 4 hereof. 
 An Option may not be exercised for a fraction of a Share. 
  

 -4- 

 An Option shall be deemed to be exercised when written notice of such exercise has been given to the
Company in accordance with the terms of the Option by the person entitled to exercise the Option and full payment for the Shares with respect to which the Option is exercised has been received by the Company. Full payment may consist of any
consideration and method of payment allowable under Section 7 of the Plan. Until the issuance (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company) of the stock certificate
evidencing such Shares, no right to vote or receive dividends or any other rights as a shareholder shall exist with respect to the Optioned Stock, notwithstanding the exercise of the Option. A share certificate for the number of Shares so acquired
shall be issued to the Optionee as soon as practicable after exercise of the Option. No adjustment shall be made for a dividend or other right for which the record date is prior to the date the stock certificate is issued, except as provided in
Section 10 of the Plan. 
 Exercise of an Option in any manner shall result in a decrease in the number of Shares which thereafter may
be available, both for purposes of the Plan and for sale under the Option, by the number of Shares as to which the Option is exercised. 
 (b) Termination of Continuous Status as a Director. Subject to Section 10 hereof, in the event an Optionee’s status as a Director terminates (other than the Optionee’s death or total and permanent disability
(as defined in Section 22(e)(3) of the Code)), the Optionee may exercise his or her Option, but only within six (6) months following the date of such termination, and only to the extent that the Optionee was entitled to exercise it on the
date of such termination (but in no event later than the expiration of its ten (10) year term). To the extent that the Optionee was not entitled to exercise an Option on the date of such termination, and to the extent that the Optionee does not
exercise such Option (to the extent otherwise so entitled) within the time specified herein, the Option shall terminate. 
 (c) Disability
of Optionee. In the event an Optionee’s status as a Director terminates as a result of total and permanent disability (as defined in Section 22(e)(3) of the Code), the Optionee may exercise his or her Option, but only within twelve
(12) months following the date of such termination, and only to the extent that the Optionee was entitled to exercise it on the date of such termination (but in no event later than the expiration of its ten (10) year term). To the extent
that the Optionee was not entitled to exercise an Option on the date of termination, or if the Optionee does not exercise such Option (to the extent otherwise so entitled) within the time specified herein, the Option shall terminate. 
 (d) Death of Optionee. In the event of an Optionee’s death, the person or entity designated as beneficiary in writing by the
Optionee, or, if no such person or entity has been designated as beneficiary by the Optionee, the Optionee’s estate or a person who acquired the right to exercise the Option by bequest or inheritance may exercise the Option, but only within
twelve (12) months following the date of death, and only to the extent that the Optionee was entitled to exercise it on the date of death (but in no event later than the expiration of its ten (10) year term). To the extent that the
Optionee was not entitled to exercise an Option on the date of death, and to the extent that the Optionee’s estate or a person who acquired the right to exercise such Option does not exercise such Option (to the extent otherwise so entitled)
within the time specified herein, the Option shall terminate. 
 9. Non-Transferability of Options. The Option may not be sold,
pledged, assigned, hypothecated, transferred, or disposed of in any manner other than by will or by the laws of descent or distribution and may be exercised, during the lifetime of the Optionee, only by the Optionee. 
  

 -5- 

 10. Adjustments Upon Changes in Capitalization, Dissolution, Merger or Asset
Sale. 
 (a) Changes in Capitalization. Subject to any required action by the shareholders of the Company, the number of Shares
covered by each outstanding Option, the number of Shares which have been authorized for issuance under the Plan but as to which no Options have yet been granted or which have been returned to the Plan upon cancellation or expiration of an Option, as
well as the price per Share covered by each such outstanding Option shall be proportionately adjusted for any increase or decrease in the number of issued Shares resulting from a stock split, reverse stock split, stock dividend, combination or
reclassification of the Common Stock, or any other increase or decrease in the number of issued Shares effected without receipt of consideration by the Company; provided, however, that conversion of any convertible securities of the Company shall
not be deemed to have been “effected without receipt of consideration.” Except as expressly provided herein, no issuance by the Company of shares of stock of any class, or securities convertible into shares of stock of any class, shall
affect, and no adjustment by reason thereof shall be made with respect to, the number or price of Shares subject to an Option. 
 (b)
Dissolution or Liquidation. In the event of the proposed dissolution or liquidation of the Company, to the extent that an Option has not been previously exercised, it shall terminate immediately prior to the consummation of such proposed
action. 
 (c) Merger or Asset Sale. In the event of a merger of the Company with or into another corporation or the sale of
substantially all of the assets of the Company, outstanding Options may be assumed or equivalent options may be substituted by the successor corporation or a Parent or Subsidiary thereof (the “Successor Corporation”). If an Option is
assumed or substituted for, the Option or equivalent option shall continue to be exercisable as provided in Section 4 hereof for so long as the Optionee (or, in the case of an entity Optionee, such Optionee’s Representative Director)
serves as a Director or a director of the Successor Corporation. Following such assumption or substitution, if the Optionee’s (or, in the case of an entity Optionee, such Optionee’s Representative Director’s) status as a Director or
director of the Successor Corporation, as applicable, is terminated other than upon a voluntary resignation by the Optionee (or, in the case of an entity Optionee, such Optionee’s Representative Director), the Option or option shall become
fully exercisable, including as to Shares for which it would not otherwise be exercisable. Thereafter, the Option or option shall remain exercisable in accordance with Sections 8(b) through (d) above. 
 If the Successor Corporation does not assume an outstanding Option or substitute for it an equivalent option, the Option shall become fully vested and
exercisable, including as to Shares for which it would not otherwise be exercisable. In such event the Board shall notify the Optionee that the Option shall be fully exercisable for a period of thirty (30) days from the date of such notice, and
upon the expiration of such period the Option shall terminate. 
 For the purposes of this Section 10(c), an Option shall be considered
assumed if, following the merger or sale of assets, the Option confers the right to purchase or receive, for each Share of Optioned Stock subject to the Option immediately prior to the merger or sale of assets, the consideration (whether stock,
cash, or other securities or property) received in the merger or sale of assets by holders of Common Stock for each Share held on the effective date of the transaction (and if holders were offered a choice of consideration, the type of consideration
chosen by the holders of a majority of the outstanding Shares). 
  

 -6- 

 11. Amendment and Termination of the Plan. 
 (a) Amendment and Termination. Except as set forth in Section 4, the Board may at any time amend, alter, suspend, or discontinue the Plan, but
no amendment, alteration, suspension, or discontinuation shall be made which would impair the rights of any Optionee under any grant theretofore made, without such Optionee’s consent. In addition, to the extent necessary and desirable to comply
with any other applicable law or regulation (including any rule of a stock exchange or automated stock quotation system upon which the shares are traded), the Company shall obtain shareholder approval of any Plan amendment in such a manner and to
such a degree as required. 
 (b) Effect of Amendment or Termination. Any such amendment or termination of the
Plan shall not affect Options already granted and such Options shall remain in full force and effect as if this Plan had not been amended or terminated. 
 12. Time of Granting Options. The date of grant of an Option shall, for all purposes, be the date determined in accordance with Section 4 hereof. 
 13. Conditions Upon Issuance of Shares. Shares shall not be issued pursuant to the exercise of an Option unless the exercise
of such Option and the issuance and delivery of such Shares pursuant thereto shall comply with all relevant provisions of law, including, without limitation, the Securities Act of 1933, as amended, the Exchange Act, the rules and regulations
promulgated thereunder, state securities laws, and the requirements of any stock exchange upon which the Shares may then be listed, and shall be further subject to the approval of counsel for the Company with respect to such compliance. 

As a condition to the exercise of an Option, the Company may require the person exercising such Option to represent and warrant at the time of any
such exercise that the Shares are being purchased only for investment and without any present intention to sell or distribute such Shares, if, in the opinion of counsel for the Company, such a representation is required by any of the aforementioned
relevant provisions of law. 
 Inability of the Company to obtain authority from any regulatory body having jurisdiction, which authority is
deemed by the Company’s counsel to be necessary to the lawful issuance and sale of any Shares hereunder, shall relieve the Company of any liability in respect of the failure to issue or sell such Shares as to which such requisite authority
shall not have been obtained. 
 14. Reservation of Shares. The Company, during the term of this Plan, will at all times
reserve and keep available such number of Shares as shall be sufficient to satisfy the requirements of the Plan. 
 15. Option
Agreement. Options shall be evidenced by written option agreements in such form as the Board shall approve. 
  

 -7-Employment Letter

 Exhibit 10.44 
 July 29, 2009 
 Laurence Corash 
 Re:
Employment Terms 
 Dear Larry: 
 This letter agreement (the
“Agreement”) memorializes your employment terms with Cerus Corporation (“Cerus” or the “Company”), including your new position and compensation terms. These terms became effective as of May 1,
2009 (the “Effective Date”). You must sign and return this Agreement within five (5) business days after receipt of the final Agreement in order to accept continued employment with Cerus under the terms provided herein.

 POSITION AND DUTIES 
 Your position is the full-time position of Sr. Vice President & Chief Medical and Chief Scientific Officer. Your primary role will be to provide commercial support for the INTERCEPT products by cultivating
and maintaining key relationships with outside business partners, investment community, patient advocacy organizations, scientific and clinical advisors, and therapeutic thought-leaders, and to represent Cerus in government relation programs.
You will report to Claes Glassell, President and CEO, and you will work at the Company’s offices in Concord, California. The Company may change your position, duties, reporting relationship, hours, and work location from time to time in its
discretion. 
 COMPENSATION, BENEFITS AND EQUITY 
 You will be paid semi-monthly at the base salary rate of $10,156.25, which calculates to an annual salary of $243,750.00 (the quoting of an annual salary is for
illustrative purposes only). The combined annual value of your base salary and annual stock award (described below) is anticipated to be approximately $375,000, subject to change as provided herein. As discussed with you, the Company agrees that the
base salary and stock program (as defined below) will not be modified without your consent for at least one (1) year from the effective date, conditioned on your continued employment. Thereafter, the Company will review your compensation terms
for potential modification. We agree that this guaranteed minimal compensation structure does not modify your at-will employment status, and both you and the Company retain the discretion to terminate your employment at any time, with or without
cause, and with or without advance notice. 

 In addition, you will receive an annual stock award if you remain an employee in good standing through the end of each
calendar year; or, if this annual stock award program (the “Stock Program”) is terminated by the Company mid-year during your continued employment, you will receive a prorated stock award for the calendar year in which the Stock
Program is terminated (with the proration to be based on the date that the Stock Program is terminated, in the same manner as the stock award will be prorated in the event of termination of your employment). The stock award will be provided to you
on or about the first business day of the following calendar year; or, if the Stock Program is terminated mid-year, the prorated stock award will be provided to you within thirty (30) days after termination of the Stock Program. The number of
shares of stock for the award will be determined by: (1) taking the dollar amount that is equivalent to 53.85% of the total base salary paid to you for the applicable “stock award” calendar year (provided that, for 2009, the dollar
amount will be 53.85% of the total base salary paid to you between the Effective Date and December 31, 2009), and (2) dividing the resulting number by the average daily closing price for Cerus stock during the applicable bonus year
(provided that, for 2009, this time period will be from the Effective Date through December 31, 2009, rather than all of 2009). If your employment terminates for any reason prior to the end of a calendar year in which the Stock Program remains
in effect (whether such termination of employment is at your request or the Company’s request), then you will receive a partial stock award that will be prorated (both in determination of the dollar amount and the average daily closing price
for the Company’s stock) based on your employment termination date. You will remain eligible for annual stock awards as described in this paragraph each calendar year during your continued employment, unless the Company provides you written
notice that this Stock Program is terminated (or otherwise modified), as determined in the Company’s sole discretion. Notwithstanding the foregoing conditions, the Board retains the sole discretion to pay you a cash award equal to 53.85% of
your base salary (to be paid no later than March 15 of the following calendar year) rather than provide any stock awards under the Stock Program, or a prorated cash award that is equal to a prorated portion of your base salary in lieu of a
prorated stock award (if you are otherwise eligible for a prorated stock award at such time rather than a full stock award). 
 In addition, you will
continue to participate in the Company’s Cash Bonus Plan for Senior Management of Cerus Corporation (the “Bonus Plan”), in accordance with the terms, conditions and limitations of the Bonus Plan. However, for any annual bonus
provided, the “cash” portion of the bonus will be paid 65% in cash and 35% in Cerus stock. Annual bonuses are not guaranteed and such bonuses, if any, are awarded at the sole discretion of the Company’s Board of Directors
(“Board”). For purposes of calculating any annual bonus under the Bonus Plan, the Board will use the combined annual value of your base salary and stock award provided under the Stock Program during years in which the Stock Program
remains in effect, rather than your base salary alone. As provided in the Bonus Plan, you must remain employed through the date the bonus is paid in order to earn and be eligible to receive a bonus; no pro rata or partial bonuses will be provided.
The Board shall have the sole discretion to change or eliminate the Bonus Plan at any time, and to determine the amount of bonus earned, if any. 
 In
addition to your base salary and stock awards under the Stock Program, you will continue to participate in all of Cerus’ standard employee benefits plans in accordance with the terms and conditions of such plans, which include employer
subsidized medical, dental and vision plan coverage, long term disability insurance, life insurance, a 401(k) plan, and Cerus’ Employee Stock Purchase Plan. You will also accrue paid vacation at the annual rate of 20 days. You should note that
Cerus may modify compensation and benefits from time to time in its discretion. 

 Your stock options will continue to vest on their current vesting schedules, and nothing in this Agreement is intended to
alter your existing stock options with the Company. In addition to any equity awards you have previously received, you shall be eligible to receive additional equity awards under the Company’s 2008 Equity Incentive Plan and various equity
incentive and bonus programs that may be approved from time to time by the Board in its sole discretion. Of course, additional equity awards are not guaranteed. 
 ADDITIONAL TERMS OF EMPLOYMENT 
 Normal working hours are from 8:00 a.m. to 5:00
p.m., Monday through Friday. As an exempt employee, you will be occasionally asked to work additional hours as required by your assignments and you will not be eligible for overtime compensation. 
 As a Cerus employee you will be expected to continue to abide by Company rules and regulations. From time to time, you will be specifically required to sign an
acknowledgment that you have read, understand and will comply with the Company rules and policies contained in the Cerus Employee Handbook. In addition, you must continue to comply with the Proprietary Information and Inventions Agreement that you
entered into previously in connection with your employment (the “Proprietary Information Agreement”). 
 In your work for the Company, you
will be expected not to make unauthorized use or disclosure of any confidential information or materials, including trade secrets, of any former employer or other third party to whom you have an obligation of confidentiality. Rather, you will be
expected to use only that information generally known and used by persons with training and experience comparable to your own, which is common knowledge in the industry or otherwise legally in the public domain, or which is otherwise provided or
developed by the Company. By continuing employment with the Company, you are representing to us that you will be able to perform your duties within the guidelines set forth in this paragraph. In addition, by signing this Agreement, you confirm to
the Company that you have no contractual commitments or other legal obligations that might restrict your activities on behalf of the Company in any manner. 
 AT-WILL EMPLOYMENT STATUS 
 Your employment status with Cerus is at-will
employment. Accordingly, as an employee you may terminate employment at any time and for any reason whatsoever upon notice to Cerus. Although not required, we request that, in the event of resignation, you give the Company at least two weeks notice
to aid in an orderly transition of your duties and responsibilities. Cerus may terminate your employment at any time, with or without cause and with or without advance notice. 
 MISCELLANEOUS 
 This Agreement, including the Proprietary Information Agreement and your equity award
agreement(s), constitutes the complete, final and exclusive embodiment of the entire agreement between the Company and you with regard to your employment terms, and it supersedes and replaces any other agreements (whether written or unwritten) you
may have with the Company, 

 
provided however, that this Agreement does not alter or affect the Cerus Corporation Change of Control Severance Benefit Plan. This Agreement is
entered into without reliance on any promise or representation, written or oral, other than those expressly contained herein, and it supersedes any other such promises, warranties or representations. Changes in your employment terms, other than
those changes expressly reserved to the Company’s or Board’s discretion in this Agreement, require a written modification signed by an officer of the Company and by you. This Agreement shall be construed and enforced in accordance with the
laws of the State of California without regard to conflicts of law principles. Any ambiguity in this Agreement shall not be construed against either party as the drafter. Any waiver of a breach of this Agreement, or rights hereunder, shall be in
writing and shall not be deemed to be a waiver of any successive breach or rights hereunder. This Agreement may be executed in counterparts which shall be deemed to be part of one original, and facsimile signatures shall be equivalent to original
signatures. 
 To indicate your understanding and acceptance of continued employment with the Company under these terms, please sign and date below, and
return this Agreement to me within five (5) business days. You may retain the enclosed additional copy of this Agreement for your files. 
 We look
forward to your favorable reply and to continuing our productive work relationship. 
 Sincerely, 
  

	
	 /s/    Claes Glassell

	Claes Glassell
	President and Chief Executive Officer

  

									
	Understood and Accepted	  	 /s/    Laurence Corash
	  		 		 	Date 7/30/09
		  	Laurence Corash

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00161-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00161-of-00352.parquet"}]]